Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release German Federal Joint Committee G Ba Issues Nationwide Reimbursement Decision For Endopredict Breast Cancer Prognostic Test is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
German Federal Joint Committee (G-BA) Issues Exclusive Nationwide Reimbursement Decision for Oncotype DX Breast Recurrence Score® Test
GENEVA, June 21, 2019 /PRNewswire/ -- Genomic Health announced today that the German Federal Joint Committee (G-BA) issued a positive reimbursement decision for the Oncotype DX Breast Recurrence ... Read More
German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test - Yahoo Finance
/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/SALT LAKE CITY, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader ... Read More
German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany - Business Wire
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced that the German Federal Joint Committee, or G-BA, has updated its directive for Contracted Medical Care to include ... Read More
Myriad Genetics, Inc.: German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict Breast Cancer Prognostic Test - FinanzNachrichten.de
Donnerstag, 19.06.2025 - Börsentäglich über 12.000 News +435 % Beteiligungsrendite durch TAO nach £5 Mio. Finanzierung und Bitcoin-Treasury-Strategie! Anzeige. Indizes Kurs % News ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus